eagle-i
 
University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Vincristine-topotecan-cyclophosphamide to standard chemotherapy in initial reaction of non-metastatic Ewing sarcoma

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-c432-e940-eee5-4adc80000000

Resource Type

  1. Clinical trial

Properties

  1. Intervention
    Vincristine
  2. Intervention
    Topotecan
  3. Intervention
    Cyclophosphamide
  4. Additional Topic(s)
    Antineoplastic Combined Chemotherapy Protocols
  5. Resource Description
    Purpose: This randomized phase III trial is studying combination chemotherapy in treating patients with non-metastatic extracranial Ewing sarcoma.
  6. Contact
    Berenberg, Jeffrey
  7. PI
    Wilkinson, Robert, M.D.
  8. Topic
    peripheral primitive neuroectodermal tumor
  9. Study Population
    Ages available for study: Up to 50 years
  10. Funded by
    Children's Oncology Group
  11. Phase
    Phase 3 clinical trial
  12. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Inferred Types from the eagle-i Ontology (What is an ontology?)
Provenance Metadata About This Resource Record
  1. workflow state
    Published
  2. contributor
    nvasilevsky
  3. created
    2011-06-24T19:31:10.105-05:00
  4. creator
    awendicke (Annemarie Wendicke)
  5. modified
    2011-09-23T11:08:36.074-05:00
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016